SMARCA2 and lung cancer: In addition, ovarian and lung cancers deficient in one SWI/SNF subunit appear sensitive to loss (by RNAi depletion) of the alternative subunit [33, 34], e.g. SMARCA2 depletion in SMARCA4-deficient lung cancer cells.